Lazard Asset Management’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,919
Closed -$163K 2304
2025
Q1
$163K Sell
35,919
-1,111
-3% -$6.12K ﹤0.01% 1682
2024
Q4
$225K Sell
37,030
-19,963
-35% -$136K ﹤0.01% 1572
2024
Q3
$448K Sell
56,993
-10,912
-16% -$110K ﹤0.01% 1387
2024
Q2
$761K Buy
67,905
+51,109
+304% +$597K ﹤0.01% 1052
2024
Q1
$212K Buy
+16,796
New +$221K ﹤0.01% 1274
2023
Q3
Sell
-5,241
Closed -$70K 2270
2023
Q2
$70K Buy
+5,241
New +$61.5K ﹤0.01% 1715
2023
Q1
Sell
-4,089
Closed -$49K 2302
2022
Q4
$49K Buy
+4,089
New +$53.1K ﹤0.01% 1822
2021
Q3
Sell
-2,749
Closed -$38K 2153
2021
Q2
$38K Buy
+2,749
New +$38.8K ﹤0.01% 1696

Other funds holding BIOX

Lazard Asset Management's BIOX Position: Q2 2025 in Review

Lazard Asset Management sold out of Bioceres Crop Solutions (BIOX) in Q2 2025, closing a stake of 35,919 shares — an estimated $163K sold.

Lazard Asset Management first reported a position in BIOX in Q2 2021 and held it in 8 quarters. The position peaked at $761K in Q2 2024. 39 funds tracked by Wall St. Rank hold BIOX as of Q2 2025.

  • Lazard Asset Management reported no remaining Bioceres Crop Solutions position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 35,919 Bioceres Crop Solutions shares in Q2 2025, an estimated $163K.
  • Lazard Asset Management first reported a position in Bioceres Crop Solutions in Q2 2021 and held it in 8 quarters.
  • Lazard Asset Management's Bioceres Crop Solutions position peaked at $761K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.